Marisa Klein-Gitelman
Pediatric Rheumatology · Chicago, ILNPI 1336104348
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $44,250 of the $44,545 with a category attached, or 99.3%. AstraZeneca accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest.
Across 5 payments — averaging $8908.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$45K
- GSK$32
Across 103 payments — averaging $8915.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$361K
- AbbVie$296K
- E.r. Squibb & Sons, L.L.C.$250K
- UCB GmbH$8K
- Novartis$4K
What the payments were for
- Consulting fees$44,25099%
- Food & beverage$2951%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $44,513 |
| GSK | 1 | $32 |
How this compares
Too few pediatric rheumatology providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Other pediatric rheumatology in Chicago
- Cuoghi EdensChicago$4K
- Brian NolanChicago$329
- Pooja PatelChicago$324
- Dierdre de RanieriChicago$125
- Nissim StolbergChicago$79
- Angela ChunChicago$62
- Michael MillerChicago$33
- Melissa TesherChicago$0
- Linda Wagner-WeinerBurr Ridge$53
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.